IMMUCELL CORP /DE/·4

Apr 14, 3:38 PM ET

Tomsche David Scott 4

4 · IMMUCELL CORP /DE/ · Filed Apr 14, 2026

Research Summary

AI-generated summary of this filing

Updated

Immucell (ICCC) Director David Tomsche Receives 10,000-Share Award

What Happened

  • Director David Scott Tomsche was granted a 10,000-share derivative award (reported as $0.00 per share) on April 16, 2025. The filing characterizes the grant as compensation for board services rather than an open-market purchase or sale.

Key Details

  • Transaction date: 2025-04-16; Grant type: Award/derivative (Code A).
  • Price reported: $0.00 per share; reported acquisition value: $0.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Filing date: 2026-04-14 — this Form 4 was filed roughly one year after the transaction (late filing).
  • Remark in filing: options were granted by the issuer to compensate directors for services on the issuer's board.

Context

  • This was a director compensation grant (derivative award). The filing does not indicate exercises, immediate sales, vesting schedule, or tax-withholding actions. Grants for board service are routine compensation and do not by themselves indicate the director is buying or selling shares in the market. The late filing means the disclosure of the grant was delayed on public record.

Insider Transaction Report

Form 4
Period: 2025-04-16
Transactions
  • Award

    Non Qualified Stock Options (Right to buy)

    2025-04-16+10,00010,000 total
    Exercise: $5.49From: 2028-04-16Exp: 2030-04-16Common Stock (10,000 underlying)
Signature
/s/ Timothy C. Fiori Attorney-in-Fact|2026-04-14

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 TOMSCHE, DAVID 04/14/26